Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21

Nature Genetics
T A MansfieldR P Lifton

Abstract

Essential hypertension is a common multifactorial trait. The molecular basis of a number of rare diseases that after blood pressure in humans has been established, identifying pathways that may be involved in more common forms of hypertension. Pseudohypoaldosteronism type II (PHAII, also known as familial hyperkalaemia and hypertension or Gordon's syndrome; OMIM #145260), is characterized by hyperkalaemia despite normal renal glomerular filtration, hypertension and correction of physiologic abnormalities by thiazide diuretics. Mild hyperchloremia, metabolic acidosis and suppressed plasma renin activity are variable associated findings. The pathogenesis of PHAII is unknown, although clinical studies indicate an abnormality in renal ion transport. As thiazide diuretics are among the most efficacious agents in the treatment of essential hypertension, understanding the pathogenesis of PHAII may be of relevance to more common forms of hypertension. Analysis of linkage in eight PHAII families showing autosomal dominant transmission demonstrates locus heterogeneity of this trait, with a multilocus lod score of 8.1 for linkage of PHAII to chromosomes 1q31-q42 and 17p11-q21. Interestingly, the chromosome-17 locus overlaps a syntenic int...Continue Reading

References

Jul 18, 1992·Lancet·R D GordonM Stowasser
Sep 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G I BellW J Rutter
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M LathropJ Ott
Apr 1, 1995·Computers and Biomedical Research, an International Journal·S K GuptaW Zwaenepoel
Jun 1, 1994·Journal of Endocrinological Investigation·S MuhammadJ R Tucci
Jul 1, 1994·Human Heredity·A A SchäfferR W Cottingham
Aug 22, 1964·The Medical Journal of Australia·W K PAVER, G J PAULINE

❮ Previous
Next ❯

Citations

Jan 31, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Dieter RosskopfRafael Schäfers
Apr 15, 2009·The Journal of Membrane Biology·Min-Hwang ChangMichael F Romero
Jul 21, 2007·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Eri NishiharaFumihiro Sugiyama
Jul 25, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·V Matti Vehaskari
Mar 29, 2001·Current Hypertension Reports·M Stoll, H J Jacob
Feb 15, 2001·Current Hypertension Reports·A E Kwitek-Black, H J Jacob
Sep 12, 2000·Current Hypertension Reports·N Kato, C Julier
Apr 6, 2005·Trends in Endocrinology and Metabolism : TEM·Kristopher T KahleRichard P Lifton
Feb 9, 2000·Pharmacology & Therapeutics·M K Agarwal, M Mirshahi
Apr 13, 2000·Pharmacology & Therapeutics·K Nakagawa, T Ishizaki
Sep 1, 2001·Trends in Cardiovascular Medicine·G Q Daley, M Cargill
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·David G Warnock
Sep 5, 2001·Clinical Genetics·A L DeStefanoF Schwartz
Mar 21, 2002·Clinical and Experimental Pharmacology & Physiology·J M AchardX Jeunemaitre
Apr 5, 2003·Annals of Human Genetics·J KnightM J Caulfield
Jun 26, 2001·Kidney International·F C Luft
Nov 8, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sebastien FaureJean-Michel Achard
Aug 12, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·M W StateJ F Leckman
Jul 1, 1999·The Journal of Cardiovascular Nursing·S K Ambler, R D Brown
Aug 10, 2004·Current Opinion in Nephrology and Hypertension·Kristopher T KahleRichard P Lifton
Nov 23, 2010·Current Opinion in Nephrology and Hypertension·Mark Glover, Kevin M O'shaughnessy
May 26, 2011·Current Opinion in Nephrology and Hypertension·Annie Mercier-Zuber, Kevin M O'Shaughnessy
Apr 26, 2000·Genome Research·M StollH J Jacob
Nov 11, 1998·Clinical and Experimental Pharmacology & Physiology. Supplement·B J Morris, L R Griffiths
Nov 30, 1999·Archives of Disease in Childhood·D V Milford
Mar 12, 2013·Heart·Joanne Maree Lind, Christine Laiwan Chiu
Apr 11, 2006·Annual Review of Nutrition·Kevin M O'Shaughnessy, Fiona E Karet
Feb 5, 2002·Annual Review of Physiology·Eric Delpire, David B Mount
Feb 5, 2002·Annual Review of Physiology·David G Warnock
Oct 27, 2007·Annual Review of Physiology·Kristopher T KahleRichard P Lifton
May 29, 2009·American Journal of Physiology. Renal Physiology·Gerardo Gamba
Jul 16, 2005·Nephron. Physiology·Graeme Mindel, Aubrey R Morrison
Jun 13, 2008·American Journal of Nephrology·Pedro San-CristobalGerardo Gamba
Apr 16, 2004·The Journal of Clinical Investigation·Kevin M O'Shaughnessy, Fiona E Karet
Oct 26, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·T SugiyamaY Yazaki
Jul 24, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Norihiro Kato
Jun 3, 2005·Clinical Medicine & Research·Friedrich C Luft
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Danielle Chabardès-GaronneJean-Marc Elalouf
Nov 1, 2002·Proceedings of the National Academy of Sciences of the United States of America·Arya ManiRichard P Lifton
Apr 29, 2014·Briefings in Functional Genomics·Louise V Wain
May 7, 2011·Journal of the American Society of Nephrology : JASN·Lihe ChenWenzheng Zhang
Mar 31, 2009·Clinical and Experimental Hypertension : CHE·Ming LuLi Jin
Sep 17, 2005·Kidney International·Katerina HodanováStanislav Kmoch

❮ Previous
Next ❯

Related Concepts

Related Feeds

BioHub - Researcher Network

The Chan-Zuckerberg Biohub aims to support the fundamental research and develop the technologies that will enable physicians to cure, prevent, or manage all diseases in our childrens' lifetimes. The CZ Biohub brings together researchers from UC Berkeley, Stanford, and UCSF. Find the latest research from the CZ Biohub researcher network here.